Agenus (AGEN) Current Assets (2010 - 2026)
Agenus (AGEN) posted quarterly Current Assets of $95.3 million for Q1 2026, up 311.81% year-over-year from $23.1 million in Q1 2025, and down 28.59% quarter-over-quarter from $133.4 million in Q4 2025.
Analysis
Agenus (AGEN) Current Assets (2010 - 2026) Analysis & Trends
Agenus' Current Assets history runs 17 years deep, the most recent figure standing at $95.3 million for Q1 2026.
- In Q1 2026, Current Assets rose 311.81% year-over-year to $95.3 million; the TTM figure through Mar 2026 stood at $95.3 million (up 311.81% YoY), while the FY2025 annual figure was $133.4 million, up 192.79% from the prior year.
- Current Assets for Q1 2026 stood at $95.3 million, down from $133.4 million in the prior quarter.
- The five-year high for Current Assets was $290.5 million in Q1 2022, with the low at $13.3 million in Q2 2025.
- The 5-year median for Current Assets is $125.6 million (2023), against an average of $136.1 million.
- The sharpest annual moves came in 2025 and 2026: Current Assets tumbled 86.66% in 2025, then surged 311.81% in 2026.
- Agenus' Current Assets stood at $213.1 million in 2022, then tumbled by 47.25% to $112.4 million in 2023, then plunged by 59.46% to $45.6 million in 2024, then jumped by 192.79% to $133.4 million in 2025, then retreated by 28.59% to $95.3 million in 2026.
- Business Quant data shows AGEN's Current Assets at $95.3 million in Q1 2026, $133.4 million in Q4 2025, and $134.0 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 5.82 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.03 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 7.22 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 4.62 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.76 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Agenus | 342.07 Mn | 342.07 Mn | 34.52 Mn | 78.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 78.81 Mn |
| Mar 31, 2026 | 95.28 Mn |
| Dec 31, 2025 | 133.44 Mn |
| Sep 30, 2025 | 133.95 Mn |
| Jun 30, 2025 | 13.34 Mn |
| Mar 31, 2025 | 23.14 Mn |
| Dec 31, 2024 | 45.57 Mn |
| Sep 30, 2024 | 50.15 Mn |
| Jun 30, 2024 | 100.00 Mn |
| Mar 31, 2024 | 60.35 Mn |
| Dec 31, 2023 | 112.42 Mn |
| Sep 30, 2023 | 125.55 Mn |
| Jun 30, 2023 | 170.74 Mn |
| Mar 31, 2023 | 205.69 Mn |
| Dec 31, 2022 | 213.12 Mn |
| Sep 30, 2022 | 251.43 Mn |
| Jun 30, 2022 | 288.93 Mn |
| Mar 31, 2022 | 290.48 Mn |
| Dec 31, 2021 | 331.97 Mn |
| Sep 30, 2021 | 308.40 Mn |